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Rationale: Diesel exhaust enhances allergic inflammation, and pollu-
tants are associated with heightened susceptibility to viral respira-
tory infections. The effects of combined diesel and virus exposure in
humans are unknown.
Objectives: Testwhetheracuteexposure todieselmodifies inflamma-
tory responses to influenza virus in normal humans and those with
allergies.
Methods: We conducted a double-blind, randomized, placebo-
controlled studyof nasal responses to live attenuated influenza virus
in normal volunteers and those with allergic rhinitis exposed to die-
sel (100mg/m3)or clean air for 2hours, followedby standarddoseof
virus and serial nasal lavages. Endpoints were inflammatory media-
tors (ELISA) and virus quantity (quantitative reverse-transcriptase
polymerase chain reaction). To test for exposure effect, we used
multiple regression with exposure group (diesel vs. air) as the main
explanatory variable and allergic status as an additional factor.
Measurements and Main Results: Baseline levels of mediators did not
differ among groups. For most postvirus nasal cytokine responses,
there was no significant diesel effect, and no significant interaction
with allergy. However, diesel was associated with significantly in-
creased IFN-g responses (P ¼ 0.02), with no interaction with allergy
in the regression model. Eotaxin-1 (P ¼ 0.01), eosinophil cationic
protein (P , 0.01), and influenza RNA sequences in nasal cells (P ¼
0.03) were significantly increased with diesel exposure, linked to
allergy.
Conclusions: Short-term exposure to diesel exhaust leads to in-
creased eosinophil activation and increased virus quantity after
virus inoculation in thosewith allergic rhinitis. This is consistentwith
previous literature suggesting a diesel “adjuvant” effect promoting
allergic inflammation, and our data further suggest this changemay
be associated with reduced virus clearance.
Clinical trial registered with www.clinicaltrials.gov (NCT00617110).
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Viral respiratory infections account for a large share of human
morbidity and mortality worldwide, particularly during pandemic
outbreaks of influenza virus (1). It is well established from epi-
demiologic data that exposure to air pollutants is associated with
increased risk for severe influenza and other respiratory viral
infections (2). Although controlled human experiments to define
the mechanisms for this are difficult to design, we recently re-
ported reduced virus clearance and suppression of specific innate
immune factors in nasal secretions of smokers compared with
nonsmokers, after standard inoculation with live attenuated in-
fluenza vaccine (LAIV) (3). Influenza virus is also epidemiolog-
ically important in asthma (4, 5), and has obvious general public
health importance in its annual epidemic and pandemic forms.
Epidemiologic studies have demonstrated that exposure to air
pollution is associated with increased asthma-related hospital
admissions, medication use, and asthma exacerbation (6–8). Be-
cause respiratory viral infections are the leading cause of asthma
exacerbations, and concurrent exposure to pollutants is likely to
occur frequently, it is important to understand how air pollutants
further aggravate asthmatic and allergic inflammation and how
this impacts viral infection.
Previous studies have demonstrated that exposure to high levels
of oxidant air pollutants increases the severity of virus-induced ex-
acerbation of asthma (9). In experimental murine models, diesel
exhaust exposure has been well documented to exacerbate allergic
inflammation and Th2 immunity (10–14), and we have recently
demonstrated that prior exposure to diesel exhaust particles
increases influenza-induced exacerbation of allergic inflammation
(11). However, few studies have been done to confirm these effects
in humans.
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AT A GLANCE COMMENTARY
Scientific Knowledge on the Subject
Diesel exhaust enhances allergic inflammation, and pollu-
tants are associated with heightened susceptibility to viral
respiratory infections. The effects of combined diesel and
virus exposure in humans are unknown.
What This Study Adds to the Field
This study suggests that prior exposure to diesel exhaust
exacerbates influenza virus–induced nasal inflammation, in
particular by promoting eosinophil activation in allergic
rhinitis.
We hypothesized that in individuals with allergic rhinitis,
exposure to diesel exhaust increases allergic inflammation after
subsequent viral infection, which in turn modifies early innate
immune responses and virus clearance. To test this, we investi-
gated the effects of short-term, controlled diesel exhaust exposure
on nasal inflammatory responses to LAIV in human volunteers.
Some of the results of this study have been previously reported in
the form of an abstract.
METHODS
Study Design and Subjects
This was a randomized, double-blind, prospective study comparing the
effects of diesel exhaust (100 mg/m3, 2 h at rest) versus clean air on
subsequent nasal inflammatory responses to LAIV. At a screening
visit, a medical history was obtained and subjects underwent spirome-
try, HIV testing, pregnancy test for females, and a panel of allergy skin
tests. Subjects returned 2–4 weeks later on “Day 0” to undergo baseline
nasal lavage, followed by controlled chamber exposure to diesel ex-
haust or clean air (randomized) for 2 hours, and a standard intranasal
dose of LAIV (FluMist, MedImmune, Inc., Gaithersburg, MD) was
given 2 to 3 hours after the end of the chamber exposure. Detailed
description of the diesel exposure has been previously described (15)
and is in the online supplement. Subjects then returned to the research
facility on Days 1, 2, 3, 4, and 9 for repeat nasal lavages. Nasal lavage
was performed according to a method previously described (5). Sub-
jects were masked as to exposure, as were all technicians performing
assays on nasal lavage fluids (NLFs). Serum was obtained at the screen-
ing visit and at 21 days after LAIV inoculation.
Both healthy, nonallergic young adult volunteers, and those with al-
lergic rhinitis, age 18–40 years, were recruited. Allergic rhinitis was
defined as a history of seasonal or perennial rhinitis plus at least one
positive immediate hypersensitivity reaction to allergen among a stan-
dard panel (including Dermatophagoides farinae, Dermatophagoides
pteronyssius, grass mix, weed mix, tree mix, dog, cat, Alternaria, and
cockroach) administered at screening. Subjects were excluded for acute
symptoms within 3 weeks before study participation. Other exclusion
criteria were smoking, any cardiorespiratory disease including asthma,
immune deficiency, receipt of an influenza vaccine or documented in-
fluenza illness in the past 12 months, egg allergy, and pregnancy. Sub-
jects with no asthma history but with abnormal spirometry at screening
(FEV1 ,75% predicted) were also excluded. Subjects were prohibited
from use of inhaled medications of any kind or medications expected to
influence nasal inflammation (e.g., nonsteroidal antiinflammatory
drugs). A detailed description of the sample estimate calculation can
be found in the online supplement.
The study was approved by the University of North Carolina Bio-
medical Institutional Review Board and the US Environmental Protec-
tion Agency.
LAIV and Virus Detection
LAIV (FluMist) was purchased from MedImmune, Inc., and used
according to the manufacturer’s recommendations. Vaccine composi-
tion is described in the online supplement. Virus quantification in
NLF cells was done using quantitative reverse-transcriptase polymer-
ase chain reaction for influenza type B hemagglutinin RNA as de-
scribed previously (5). Serologic response to LAIV was measured by
hemagglutination-inhibition assay in sera obtained at screen visit and
21 days after-LAIV (see online supplement for more details).
Measurement of Mediator Levels in NLF
Inflammatory cytokines (IL-1b, IL-6, IL-10, IL-12p70, granulocyte-
macrophage colony–stimulating factor, and IFN-g) and chemokines
(IL-8, interferon-inducible protein-10, monocyte chemotactic protein
[MCP]-1, thymus and activation-regulated chemokine, eotaxin-1,
eotaxin-3, macrophage-derived chemokine, and MCP-4) were mea-
sured in NLFs using a multiplex ELISA platform (MesoScale Discov-
ery, Gaithersburg, MD) according to the manufacturer’s instructions.
Eosinophilic cationic protein (ECP) was measured in NLFs using a spe-
cific commercial ELISA kit (Medical and Biological Laboratories Co.,
Nagoya, Japan), also according to the manufacturer’s instructions.
Statistical Analysis
Raw NLF data are presented in descriptive fashion for each mediator
endpoint, and levels of most mediators tended to rise and then fall back
to baseline levels over the 9 days after LAIV inoculation (see online
supplement). To evaluate the effect of exposure and allergic status on
the mediators, we reduced the longitudinal observations for each sub-
ject to a single point representing response to LAIV, namely the area
under curve (AUC), which was calculated for fold change over base-
line. To formally test for the exposure effect, we used a sequence of
nested multiple regression models with exposure group (diesel or air)
as the main explanatory variable and allergic status (normal or allergic
rhinitis) as an additional factor. Because body mass index is known to
affect both influenza outcomes and vaccine responses in humans (16–
18), it was included in all the models. The full model is a two-way
analysis of covariance model with interaction of exposure group and
allergic status. Subsequent models tested were an additive two-way
analysis of covariance model and one-way analysis of covariance




Demographic characteristics of the subjects completing the pro-
tocol are shown in Table 1. Subjects in the normal and allergic
rhinitis groups were similar in age and body mass index. Simi-
larly, the normal and allergic rhinitis subgroups exposed to air
and diesel also did not differ in age or body mass index. In the
normal group, there were more females than males but the
distribution was similar between the diesel- and air-exposed
subgroups. One subject in the allergic rhinitis and air group
developed prominent allergic-type symptoms (sneezing and
conjunctivitis) believed to be unrelated to the study exposures.
This subject was excluded from the final analysis, making the
final n ¼ 7 for this group.
Chamber Exposure Data
Mean measured average particle exposure for subjects exposed
to diesel was 93.2 mg/m3 (range, 76.7–108.6 mg/m3), and for air-
exposed subjects did not exceed 4.5 mg/m3 in any case. Mea-
sured chamber concentration range for NO2 was 0.00–0.01 ppm
(air) and 0.86–1.32 ppm (diesel); NO concentration was 0.00–
0.03 ppm (air) and 3.26–4.67 ppm (diesel); SO2 concentration
was 0.00–0.01 ppm (air) and 0.04–0.06 ppm (diesel); and CO
concentration was 0.01–0.08 (air) and 3.08–6.00 ppm (diesel).
Subjects did not report significant symptoms with any exposure.
NLF Cytokines
AtDay 0, pre-LAIV baseline levels of NLF cytokines did not dif-
fer significantly between diesel- and air-exposure groups. For
TABLE 1. DEMOGRAPHIC CHARACTERISTICS OF NORMAL
VOLUNTEERS (NV) AND THOSE WITH ALLERGIC RHINITIS (AR)
EXPOSED TO AIR OR DIESEL EXHAUST (DE)
Group/Expos. NV/Air NV/DE AR/Air AR/DE
N 8 8 7 9
Age, yr 25.3 (5.8) 24.3 (5.9) 24.4 (4.2) 24.9 (4.6)
Body mass index 23.3 (3.2) 25.1 (5.5) 27.3 (6.6) 23.6 (4.1)
Sex, M/F 3/5 2/6 4/4 4/5
Data are shown as mean (SD).
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most cytokines, there was an increase in median levels in NLF
from Day 0 over the subsequent Days 1–4 after LAIV, with
a decline back toward baseline by Day 9 (see Figures E1–E6).
Statistical analysis of the diesel effect on post-LAIV cytokine
responses based on AUC data for ratio to baseline (AUCratio)
for IL-1b, IL-6, IL-10, IL-12p70, and granulocyte-macrophage
colony–stimulating factor responses to LAIV suggested no sta-
tistically significant effect of diesel (vs. air), and no significant
interaction with allergy status. However, for IFN-g there was
a significant diesel effect, not related to allergic status (P ¼
0.02) (Figure 1). This was true whether AUC included Days
1–9 or only Days 1–4.
NLF Chemokines and ECP
At Day 0, pre-LAIV baseline levels of NLF chemokines did not
differ significantly between diesel- and air-exposure groups, ex-
cept for thymus and activation-regulated chemokine levels, which
were higher in the diesel-exposed normal subgroup than the air-
exposed normal subgroup (P ¼ 0.01). Similar to the cytokine
responses to LAIV, most of the measured chemokines increased
during Days 1–4 after LAIV inoculation, then declined back
toward baseline by Day 9 (see Figures E7–E12). For the CXC
chemokines interferon-inducible protein-10 and IL-8, there was
no significant diesel effect in the regression model, although if
AUC excluded Day 9, a significant increase with diesel was noted
for IL-8 in those with allergic rhinitis. Among the CC chemo-
kines, eotaxin-1 (CCL11) showed a statistically significant diesel-
associated increase in the regression model, an effect interacting
with allergic status (P ¼ 0.01) (Figure 2). This was true whether
AUC included Days 1–9 or only Days 1–4.
At Day 0, pre-LAIV baseline levels of NLF ECP did not dif-
fer significantly between diesel-and air-exposure groups. In sub-
jects with allergic rhinitis exposed to diesel, ECP levels were
elevated compared with air-exposed control subjects after
LAIV, and persistently elevated at Day 9 (Figure 3A). ECP
response expressed as AUC was significantly increased with
diesel exposure in the regression model, an effect linked with
allergy status (P , 0.01) (Figure 3B). This was true whether
AUC included Days 1–9 or only Days 1–4.
Virus Quantity and Antiviral Antibody Responses
Although within-group data for influenza B hemagglutinin RNA
sequences in NLF cells were quite variable, median virus quantity
on Days 1–4 after-LAIV inoculation tended to be 1–2 log10
higher in diesel- than in air-exposed groups (Figure 4A). Because
Figure 1. (A) Time course of IFN-g in nasal lavage fluid after Day 0 in-
oculation with live attenuated influenza vaccine (LAIV) in subjects ex-
posed just before LAIV inoculation to clean air or to 100 mg/m3 diesel
exhaust particles for 2 hours at rest. Data are shown as medians at each
time point. (B) Individual area under curve (AUC) data for IFN-g in nasal
lavage fluid. Horizontal lines represent medians for each exposure
group. AR/air ¼ those with allergic rhinitis exposed to air; AR/DE ¼
those with allergic rhinitis exposed to diesel exhaust; NV/air ¼ normal
volunteers exposed to air; NV/DE ¼ normal volunteers exposed to die-
sel exhaust.
Figure 2. (A) Time course of eotaxin-1 in nasal lavage fluid after Day
0 inoculation with live attenuated influenza vaccine (LAIV) in subjects
exposed just before LAIV inoculation to clean air or to 100 mg/m3 diesel
exhaust particles for 2 hours at rest. Data are shown as medians at each
time point. (B) Individual area under curve (AUC) data for eotaxin-1 in
nasal lavage fluid. Horizontal lines represent medians for each exposure
group. AR/air ¼ those with allergic rhinitis exposed to air; AR/DE ¼
those with allergic rhinitis exposed to diesel exhaust; NV/air ¼ normal
volunteers exposed to air; NV/DE ¼ normal volunteers exposed to die-
sel exhaust.
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there was no virus in NLFs at Day 0 (pre-LAIV) baselines, AUC
analysis for influenza B hemagglutinin RNA sequences in
NLF cells used only “raw” virus quantity (AUCraw) to assess
diesel effects. Levels of viral RNA sequences in NLF cells were
significantly increased with diesel exposure, an effect modified by
allergy status (P ¼ 0.03) (Figure 4B).
Pre-LAIV hemagglutination-inhibition titers in serum did not
differ at baseline among the subject groups. Paired pre-LAIV
and 21-day post-LAIV sera were available for testing in most
subjects, and all four groups had significantly increased recipro-
cal titers after LAIV. Mean (SD) fold change increase in recip-
rocal titers after LAIV were similar among groups: normal and
air ¼ 2.5 (1), n ¼ 4; normal and diesel ¼ 2.9 (2.5), n ¼ 7; allergic
rhinitis and air ¼ 3 (2.8), n ¼ 5; and allergic rhinitis and diesel ¼
1.7 (0.5), n ¼ 7.
DISCUSSION
In a randomized, controlled sequential-exposure study in young
adults with or without allergic rhinitis, it was found that short-
term diesel exhaust exposure in a chamber setting had significant
effects on subsequent post-LAIV nasal responses, specifically an
increase in IFN-g levels and in virus quantity. Subjects with
allergic rhinitis had particularly elevated quantities of virus,
and additionally had statistically significant and prolonged in-
creases in post-LAIV eotaxin-1 and ECP responses after diesel
compared with air control subjects. Thus, individuals who are
allergic may be especially susceptible to diesel-induced eosino-
phil recruitment and activation, either as a direct result of diesel
exhaust particle interactions with nasal cell types relevant to
allergic inflammation, or secondary to diesel-induced reduction
in virus clearance. Although it has been previously reported
that young adults who smoke also have reduced clearance
of LAIV and altered nasal inflammation (5), we believe the
current study is the first to measure the impact of an inhaled
pollutant on viral respiratory infection in a controlled-exposure
setting in human volunteers.
Our results are consistent with data from experimental models
suggesting that diesel exhaust exacerbates allergic inflammation.
In ovalbumin (OVA)-sensitized BALB/c mice, exposure to diesel
exhaust particles at 2,000 mg/m3 for 4 hours per day for 4 days
resulted in increased eosinophils, neutrophils, lymphocytes, and
IL-6 in bronchoalveolar lavage fluids after OVA challenge,
whereas nonsensitized control animals responded to diesel only
with increased neutrophils (14). Data from a similar model sug-
gest that diesel exhaust particles may function as an adjuvant in the
induction of Th2 immune responses by OVA (13). Two recent
studies (10, 12) have reported that repeated exposure to low-
dose diesel exhaust after allergen challenge induced increased
Figure 3. (A) Time course of eosinophil cationic protein (ECP) in nasal
lavage fluid after Day 0 inoculation with live attenuated influenza vac-
cine (LAIV) in subjects exposed just before LAIV inoculation to clean air
or to 100 mg/m3 diesel exhaust particles for 2 hours at rest. Data are
shown as medians at each time point. (B) Individual area under curve
(AUC) data for ECP in nasal lavage fluid. Horizontal lines represent
medians for each exposure group. AR/air ¼ those with allergic rhinitis
exposed to air; AR/DE ¼ those with allergic rhinitis exposed to diesel
exhaust; NV/air ¼ normal volunteers exposed to air; NV/DE ¼ normal
volunteers exposed to diesel exhaust.
Figure 4. (A) Time course of influenza virus RNA in nasal lavage fluid
after Day 0 inoculation with live attenuated influenza vaccine (LAIV)
in subjects exposed just before LAIV inoculation to clean air or to
100 mg/m3 diesel exhaust particles for 2 hours at rest. Data are shown
as medians at each time point. (B) Individual area under curve (AUC)
data for influenza virus RNA in nasal lavage fluid. Horizontal lines rep-
resent medians for each exposure group. AR/air ¼ those with allergic
rhinitis exposed to air; AR/DE ¼ those with allergic rhinitis exposed to
diesel exhaust; NV/air ¼ normal volunteers exposed to air; NV/DE ¼
normal volunteers exposed to diesel exhaust.
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expression of macrophage-derived chemokine and the Th2 cyto-
kines IL-4, IL-5, and IL-13 in murine lung tissue. Oxidant stress
seems to be involved in diesel-associated increases in allergic in-
flammation and airway hyperresponsiveness as evidenced by
experiments in Nrf2 knockout mice (19) and exposure of
dendritic cells (DC) to diesel exhaust particle extracts (20, 21).
Ambient and diesel particulates instilled into the oropharynx have
been shown to activate pulmonary DC and promote eosinophilia
and Th2-type responses in mice (22). In a study comparing
responses to several chemically distinct preparations of diesel ex-
haust particles, potentiation of murine allergic immune responses
seemed to correlate with diesel exhaust content of polycyclic aro-
matic hydrocarbons (23). Additionally, nasal challenge studies in
humans have shown that diesel exhaust exposure predisposes to
heightened allergic responses after allergen stimulation, particu-
larly in GSTM1-null individuals (24, 25). However, conclusions
regarding the clinical or mechanistic significance of our data must
be made with caution given the fundamental differences between
LAIV and wild-type viruses (see caveats below).
Several recent reports have described experiments using hu-
man tissue to investigate mechanisms for diesel effects. In exper-
imental in vitro studies using human bronchial epithelial cells in
coculture with myeloid DC, it was reported that diesel exhaust
particles induced oxidative stress, which up-regulated epithelial
production of thymic stromal lymphopoietin, driving myeloid
DC to Th2 polarization (26). Incubation of nonatopic human pe-
ripheral blood mononuclear cells with diesel exhaust particle–
derived polyaromatic hydrocarbons resulted in increased IL-13
and decreased IFN-g production and increased chemotaxis of
Th2 lymphocytes (27). In vitro stimulation of human DC with
diesel exhaust particles induced production of several cytokines
including IFN-g, and direction of a Th2-like cytokine produc-
tion pattern by CD41 lymphocytes in coculture (28). Thus, lim-
ited research using human tissue seems consistent with data
from murine studies.
The effects of diesel exhaust exposure on susceptibility to in-
fection have also been investigated in BALB/c mice. Exposure at
varying levels and durations increased inflammatory mediators,
including IFN-g, but suppressed expression of surfactant pro-
teins A and D, which function as important host defense factors
against both bacterial and viral pathogens in the lung (29). In
murine experiments analogous to the design for the current
study, we found that OVA-sensitized C57BL/6 mice instilled
intratracheally with diesel exhaust particles, then infected with
influenza A, had increased lung levels of eosinophils and Th2
cytokines compared with mice exposed to either diesel or virus
alone (11). Furthermore, the Th2-like cytokine responses to
influenza noted in neonatal mice (compared with adults) are
associated with delayed migration of T cells to the lung, and
increased susceptibility to influenza virus infection (30). No pre-
vious studies have tested the effects of sequential exposures to
diesel exhaust and virus in human volunteers.
Epidemiologic evidence exists for an impact of diesel exhaust
or “near roadway” effects on asthma in humans, particularly
children (31). Behndig and coworkers (32) recently reported
a study of normal volunteers and subjects with mild to moderate
asthma who were exposed to a similar controlled diesel exhaust
exposure as in our study (100 mg/m3, idling truck source, 2 h with
intermittent exercise), followed by lung function testing and
bronchoscopy 18 hours later. Although the normal volunteers
had mild increases in neutrophils in the airways, those with
asthma had no change in inflammation or in bronchial hyperre-
activity, and the authors concluded that “the increased sensitivity
of individuals with asthma to traffic-related air pollution is not nec-
essarily associated with classical acute inflammation or aggravation
of standard cellular indicators of allergic asthmatic inflammation.”
It is possible that the lower airways are relatively protected
from real-world diesel exhaust effects compared with the nasal
airway, or that the diesel fuel or engine characteristics used by
Behndig and coworkers were significantly different from ours.
Furthermore, a study at our center in which diesel exhaust par-
ticles were applied directly to the nasal mucosa in volunteers
with asthma showed no inflammatory effect (33). However,
a reasonable hypothesis, consistent with our current results
and with our data in mice (11), is that lower-level exposures
may have minimal impact alone, but can predispose to exacer-
bation of allergic or asthmatic inflammation by increasing virus-
induced eosinophilic inflammation and reduced early virus
clearance. This might occur by effects of diesel exhaust on air-
way cells driving Th2 immune responses, by diesel-induced re-
duction of virus clearance through nonimmune mechanisms, or
both. Although such a sequence of events is complex and can-
not be proved in an observational human study such as this, it
could conceivably be common in individuals with allergies in
urban settings. A very similar sequence was suggested in a pre-
vious report in which severity of virus-induced exacerbation was
increased in children with asthma with recent exposure to ele-
vated levels of ambient NO2 (9).
Several caveats are appropriate for this study. First, the rel-
atively small number of subjects studied may limit definitive con-
clusions. Baseline levels of most factors in NLF were quite
variable, but the main method of data reduction for statistical
analysis (AUC for ratios to baseline) was chosen to minimize
the impact of baseline variability. Second, the temperature-
sensitive LAIV is replication-limited and does not fully mimic
a natural influenza infection, although it clearly is immunogenic
and simulates many important features of natural mucosal
host defense (34). For practical reasons and based on our prior
published experience (3), we limited our data collection to the
first several days after LAIV inoculation plus a later time point
(Day 9), leaving open the possibility that significant effects could
have been missed in the Day 5–8 interval. However, it seems
unlikely that such changes could have been sufficient to negate
the significant results observed in our analysis, which were similar
whether AUC data for Days 1–4 only or including Day 9 were
used.
Diesel exhaust particles are a complex mixture of organic car-
bons adsorbed to elemental carbons and small amounts of sul-
fates, nitrates, and minerals (35). Our study, designed to
approximate real-world exposures by using an actual truck en-
gine and levels of particulates reported in common urban sit-
uations (36), used a fuel and exposure setup identical to that
reported by Sobus and coworkers (37), but different engines
and running conditions can alter the chemical composition of
diesel exhaust, which in turn may have a significant impact on
inflammatory outcomes (23). Our study design did not include
control groups for LAIV itself, raising the possibility that any
mediator effects observed were related to the diesel or air expo-
sures alone rather than to LAIV. However, the time course and
pattern of mediator responses observed in the current study
were very similar to those in our previous LAIV study, which
did not involve diesel exposure (3), and a previous study at our
center showed no effect of diesel exhaust particles alone on
nasal inflammation (29). It seems very unlikely that the cytokine
elevations observed in the current study were independent of
LAIV. A final caveat is that nasal mucosal responses may also
not entirely mimic those in the lower airways, although there is
evidence from whole-genome studies that nasal epithelial re-
sponses resemble bronchial epithelial responses to toxins (38).
In summary, we have observed evidence for reduced nasal vi-
rus clearance and increased and prolonged virus-induced eosin-
ophil activation in those with allergic rhinitis randomized to
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exposure to low-level diesel exhaust compared with air before
LAIV inoculation. These results are consistent with data from
our previous study conducted in OVA-sensitized mice (11),
supporting the relevance of these models, and add to the evi-
dence that diesel exposure at commonly encountered levels may
influence the course of infection in humans, particularly in indi-
viduals with allergies. Although the clinical importance of this
kind of interaction cannot be defined from our data, additional
studies regarding the effect of novel preventive or treatment
strategies, such as antioxidant up-regulation, seem warranted.
Additionally, our data suggest that detailed studies of mucosal
responses to respiratory viruses may be safely performed in
humans using nasal exposure models, as we have previously shown
for LAIV (5) and as recently shown for respiratory syncytial virus
by DeVincenzo and coworkers (39). The general experimental
approach of sequential controlled exposures to environmental pol-
lutants and attenuated or well-tolerated wild-type virus strains
may allow further advances in the understanding of the complex
interactions between environmental agents and infectious diseases
in humans.
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